A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
Conditions: Nasopharyngeal Carcinoma; Neoadjuvant Chemotherapy Interventions: Drug: 4 cycles of Neoadjuvant Chemotherapy With Definitive Radiotherapy; Drug: 3 cycles of Neoadjuvant Chemotherapy With concurrent chemoradiotherapy Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Hospitals | Nasopharyngeal Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Study